"Agrochemical maker Bayer and attorneys for cancer patients announced a proposed $7.25 billion settlement Tuesday to resolve thousands of U.S. lawsuits alleging the company failed to warn people that its popular weedkiller Roundup could cause cancer. The proposed settlement comes as the U.S. Supreme Court is preparing to hear arguments on Bayer's assertion that the U.S. Environmental Protection Agency's approval of Roundup without a cancer warning should invalidate claims filed in state courts. That case would not be affected by the proposed settlement. But the settlement would eliminate some of the risk from an eventual and uncertain Supreme Court ruling both for Bayer and for patients seeking damages."
"Germany-based Bayer, which acquired Roundup maker Monsanto in 2018, disputes the assertion that the weedkiller's key ingredient, glyphosate, can cause non-Hodgkin's lymphoma. But the company has warned that mounting legal costs are threatening its ability to continue selling the product in U.S. agricultural markets. Litigation uncertainly has plagued the company for years, and this settlement gives the company a road to closure, Bayer CEO Bill Anderson said Tuesday."
Bayer and attorneys for cancer patients proposed a $7.25 billion settlement to resolve thousands of U.S. lawsuits alleging Roundup can cause cancer. The U.S. Supreme Court is preparing to hear arguments on Bayer's claim that the EPA's approval of Roundup without a cancer warning should preempt state-court claims; that case would not be affected by the settlement. The settlement would reduce legal risk for both Bayer and plaintiffs and could mitigate uncertainty from a potential Supreme Court ruling. Bayer disputes that glyphosate causes non-Hodgkin's lymphoma while warning that mounting legal costs threaten U.S. sales. The settlement was filed in St. Louis Circuit Court and requires court approval.
Read at www.mercurynews.com
Unable to calculate read time
Collection
[
|
...
]